Skip to main content
Research

Publications: Dr Manish Saxena

Heiden E, Jones T, Brogaard Maczka A, Kapoor M, Chauhan M, Wiffen L, Barham H, Holland J et al. ( 2022 ) . Measurement of Vital Signs Using Lifelight Remote Photoplethysmography: Results of the VISION-D and VISION-V Observational Studies . JMIR Form Res vol. 6 , ( 11 )
Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder RE, Lurz P, Lobo MD, Fisher NDL et al. ( 2022 ) . Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial . JAMA Cardiol
Rader F, Kirtane AJ, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, Levy T et al. ( 2022 ) . Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial . EuroIntervention vol. 18 , ( 8 ) E677 - E685 .
Collier D, Taylor M, Godec T, Shiel J, James R, Chowdury Y, Ebano P, Monk V et al. ( 2022 ) . Personalized electronic record supported optimisation when alone for patients with hypertension- pilot study for remote medical management of hypertension during the Covid-19 pandemic (personal covidBP) . JOURNAL OF HUMAN HYPERTENSION . vol. 36 , 8 - 8 .
Saxena M, Schmieder RE, Kirtane AJ, Mahfoud F, Daemen J, Basile J, Lurz P, Gosse P et al. ( 2022 ) . Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study . Journal of Human Hypertension vol. 36 , ( 7 ) 629 - 639 .
Saxena M, Von Heymann C, Santamaria A, Jin J, Chen C, Borrow A, Vanassche T, Unverdorben M et al. ( 2022 ) . Management of edoxaban in patients undergoing multiple procedures: a subanalysis of the EMIT-AF/VTE program . EP Europace vol. 24 , ( Supplement_1 )
REMAP-CAP Writing Committee for the REMAP-CAP Investigators, Bradbury CA, Lawler PR, Stanworth SJ, McVerry BJ, McQuilten Z, Higgins AM, Mouncey PR et al. ( 2022 ) . Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial . JAMA vol. 327 , ( 13 ) 1247 - 1259 .
( 2022 ) . WHOSE DOSE IS IT ANYWAY? INDIVIDUAL PATIENT DOSE-RESPONSE CURVES FROM THE REMOTE-CARE PERSONAL-COVIDBP TRIAL . Journal of the American College of Cardiology vol. 79 , ( 9 ) 1997 - 1997 .
Fisher NDL, Kirtane AJ, Daemen J, Rader F, Lobo MD, Saxena M, Abraham J, Schmieder RE et al. ( 2022 ) . Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial . Journal of Hypertension vol. 40 , ( 2 ) 221 - 228 .
Asselbergs FW, Linschoten M, Uijl A, Schut A, Jakob CEM, Romão LR, Bell RM, McFarlane E et al. ( 2022 ) . Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries . European Heart Journal vol. 43 , ( 11 ) 1104 - 1120 .
Unverdorben M, von Heymann C, Santamaria A, Saxena M, Vanassche T, Wilkins R, Jin J, Chen C et al. ( 2022 ) . Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program . PACE - Pacing and Clinical Electrophysiology vol. 45 , ( 1 ) 83 - 91 .
Unverdorben M, von Heymann C, Santamaria A, Saxena M, Vanassche T, Jin J, Laeis P, Wilkins R et al. ( 2021 ) . Correction to: Elderly patients with atrial fibrillation in routine clinical practice: peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study (BMC Cardiovascular Disorders, (2020), 20, 1, (504), 10.1186/s12872-020-01766-w) . BMC Cardiovascular Disorders vol. 21 , ( 1 )
Rader F, Kirtane A, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, Levy T et al. ( 2021 ) . Durability of Reduced Office-Measured Blood Pressure and Antihypertensive Medication Use After Ultrasound Renal Denervation: 24-Month Results From the RADIANCE-HTN SOLO Trial . JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY . vol. 78 , B152 - B152 .
von Heymann C, Unverdorben M, Colonna P, Ortiz AS, Saxena M, Vanassche T, Weitz JI, Wilkins R et al. ( 2021 ) . Management of Edoxaban Therapy in Patients Undergoing Major Surgery: A Sub-Analysis of the Prospective, Observational, Multinational Emit-AF/VTE Study . Blood vol. 138 , ( Supplement 1 ) 3024 - 3024 .
Rader F, Kirtane A, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, Levy T et al. ( 2021 ) . TCT-369 Durability of Reduced Office-Measured Blood Pressure and Antihypertensive Medication Use After Ultrasound Renal Denervation: 24-Month Results From the RADIANCE-HTN SOLO Trial . Journal of the American College of Cardiology vol. 78 , ( 19 )
Maniero C, Julu P, Shah M, Wolff C, Kapil V, Rull G, Gupta A, Saxena M et al. ( 2021 ) . Dysregulation of central respiratory modulation of cardiac vagal tone is a novel, early sign of dysautonomia in patients with alpha-synucleinopathies . JOURNAL OF HUMAN HYPERTENSION . vol. 35 , 16 - 16 .
Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, Rump LC, Persu A et al. ( 2021 ) . Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial . The Lancet vol. 397 , ( 10293 ) 2476 - 2486 .
Vanassche T, Colonna P, Santamaria A, Chen C, Von Heymann C, Jin J, Saxena M, Jiang W et al. ( 2021 ) . Periprocedural anticoagulation management in edxoaban patients undergoing catheter-based cardiovascular procedures: analyses of the noninterventional global EMIT study . EP Europace vol. 23 , ( Supplement_3 )
Unverdorben M, Colonna P, Von Heymann C, Santamaria A, Saxena M, Vanassche T, Wilkins R, Chen C ( 2021 ) . Periprocedural management of patients on edoxaban undergoing pacemaker and cardiac monitoring device implantation - a sub-analysis of the EMIT-AF/VTE study . EP Europace vol. 23 , ( Supplement_3 )
Saxena M, Kermali M, Balawon A, Pheby J, Benu E, Piniera B, Low D, Mathur A et al. ( 2021 ) . COLLATERAL BENEFITS OF PARTICIPATION IN CLINICAL RESEARCH: INSIGHTS FROM A RESISTANT HYPERTENSION TRIAL SCREEN OUT POPULATION . JOURNAL OF HYPERTENSION . vol. 39 , E370 - E370 .
Bertog S, Sharma A, Mahfoud F, Pathak A, Schmieder RE, Sievert K, Papademetriou V, Weber MA et al. ( 2021 ) . Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter . Cardiovascular Revascularization Medicine vol. 24 , 77 - 86 .
Gosse P, Cremer A, Kirtane AJ, Lobo MD, Saxena M, Daemen J, Wang Y, Stegbauer J et al. ( 2021 ) . Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study . Hypertension vol. 77 , ( 2 ) 529 - 536 .
Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M et al. ( 2020 ) . 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation . JACC: Cardiovascular Interventions vol. 13 , ( 24 ) 2922 - 2933 .
Unverdorben M, von Heymann C, Santamaria A, Saxena M, Vanassche T, Jin J, Laeis P, Wilkins R et al. ( 2020 ) . Elderly patients with atrial fibrillation in routine clinical practice—peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study . BMC Cardiovascular Disorders vol. 20 , ( 1 )
Santamaria A, Colonna P, von Heymann C, Saxena M, Vanassche T, Jin J, Wilkins R, Chen C et al. ( 2020 ) . Periprocedural Interruption of Edoxaban in Real World Setting: Results from the Emit AF/VTE Study . Blood vol. 136 , ( Supplement 1 ) 13 - 14 .
Feyz L, Wang Y, Pathak A, Saxena M, Mahfoud F, Sanghvi K, Peterson R, Kirtane AJ et al. ( 2020 ) . Using social media to recruit study participants for a randomized trial for hypertension . European Heart Journal - Digital Health vol. 1 , ( 1 ) 71 - 74 .
Saxena M, Kermali M, Balawon A, Pheby J, Benu E, Piniera B, Low D, Mathur A et al. ( 2020 ) . Collateral benefits of participation in clinical research: insights from a resistant hypertension trial screen out population . JOURNAL OF HUMAN HYPERTENSION . vol. 34 ,
Colonna P, von Heymann C, Santamaria A, Saxena M, Vanassche T, Wolpert D, Laeis P, Wilkins R et al. ( 2020 ) . Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study . Clinical Cardiology vol. 43 , ( 7 ) 769 - 780 .
Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ et al. ( 2019 ) . Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial . Circulation vol. 139 , ( 22 ) 2542 - 2553 .
McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE et al. ( 2019 ) . Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA . Circulation vol. 139 , ( 3 ) 351 - 361 .
Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M et al. ( 2019 ) . Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial . JAMA vol. 321 , ( 1 ) 69 - 79 .
Lobo MD, Sharp ASP, Kapil V, Davies J, De Belder MA, Cleveland T, Bent C, Chapman N et al. ( 2019 ) . Joint UK societies' 2019 consensus statement on renal denervation . Heart
Sharp ASP, Saxena M, Lobo MD ( 2018 ) . Renal artery sympathetic denervation: Back on track! . European Heart Journal vol. 39 , ( 46 ) 4056 - 4057 .
Mukhtar O, Cheriyan J, Cockcroft JR, Collier D, Coulson JM, Dasgupta I, Faconti L, Glover M et al. ( 2018 ) . A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial . American Heart Journal vol. 204 , 102 - 108 .
Saxena M, Shour T, Shah M, Wolff CB, Julu POO, Kapil V, Collier DJ, Ng FL et al. ( 2018 ) . Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success . J Am Heart Assoc vol. 7 , ( 12 )
Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ et al. ( 2018 ) . Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial . The Lancet vol. 391 , ( 10137 ) 2335 - 2345 .
Williams B, MacDonald TM, Morant SV, Webb DJ, Sever P, McInnes GT, Ford I, Cruickshank JK et al. ( 2018 ) . Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies . The Lancet Diabetes and Endocrinology vol. 6 , ( 6 ) 464 - 475 .
Saxena M, Sobotka P, Balmforth P, Mathur A, Jain A, Rensing B, Lobo M ( 2018 ) . IMMEDIATE, SIGNIFICANT DECLINE IN CENTRAL AND PERIPHERAL BLOOD PRESSURE WITH CENTRAL ARTERIAL VENOUS ANASTOMOSIS . Journal of Hypertension . vol. 36 ,
BROWN MJ ( 2018 ) . Investigation of the endocrine and haemodynamic changes in resistant hypertension, and its response to spironolactone or amiloride: the PATHWAY-2 mechanisms study . Lancet Diabetes and Endocrinology vol. 6 , ( 6 ) 464 - 475 .
Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B et al. ( 2018 ) . Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension-WAVE IV . Journal of Hypertension . vol. 36 , 680 - 689 .
MacDonald TM, Williams B, Webb DJ, Morant S, Caulfield M, Cruickshank JK, Ford I, Sever P et al. ( 2017 ) . Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial . J Am Heart Assoc vol. 6 , ( 11 )
Saxena M, Shour T, Shah M, Wolff C, Collier DJ, Kapil V, Balawon A, Pheby JM et al. ( 2017 ) . Attenuation of splanchnic autotransfusion following non-invasive ultrasound renal denervation: a novel marker of procedural success . JOURNAL OF HUMAN HYPERTENSION . vol. 31 , 679 - 680 .
Schmieder RE, Ott C, Toennes S, Gertner M, Dawood O, Saxena M, O’Brien B, Lobo M ( 2017 ) . [LB.01.02] PHASE II RANDOMIZED SHAM-CONTROLLED STUDY OF RENAL DENERVATION FOR SUBJECTS WITH UNCONTROLLED HYPERTENSION – WAVE IV . Journal of Hypertension . vol. 35 ,
Saxena M, Shour T, Shah M, Wolff C, Collier DJ, Kapil V, Balawon A, Pheby JM et al. ( 2017 ) . [LB.03.06] ATTENUATION OF SPLANCHNIC AUTOTRANSFUSION FOLLOWING NON-INVASIVE ULTRASOUND RENAL DENERVATION . Journal of Hypertension . vol. 35 , e77 - e78 .
Ormiston J, Neuzil P, O’brien B, Saxena M, Schmieder RE, Gertner M, Dawood O, Lobo MD ( 2017 ) . [PP.15.25] REDO RENAL DENERVATION WITH NON-INVASIVE THERAPEUTIC ULTRASOUND . Journal of Hypertension . vol. 35 ,
Lobo M, Montarello J, Saxena M, Jain A, Walters D, Pincus M, Worthley S ( 2017 ) . [PP.15.26] RENAL DENERVATION USING THE ENLIGHTN RENAL DENERVATION SYSTEM IN ALTERNATIVE HYPERTENSIVE POPULATIONS . Journal of Hypertension . vol. 35 ,
SAXENA M, Shour T, Sobotka P, Jain A, Collier DJ, Hamshere S, Mathur A, Knight C et al. ( 2017 ) . [PP.24.26] ANTIHYPERTENSIVE EFFECTS OF A CENTRAL ARTERIOVENOUS ANASTOMOSIS ARE MEDIATED THROUGH PROFOUND REDUCTION IN SYSTEMIC VASCULAR RESISTANCE . Journal of Hypertension . vol. 35 , e293 - e294 .
Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E et al. ( 2017 ) . Central iliac arteriovenous anastomosis for uncontrolled hypertension: One-year results from the ROX CONTROL HTN trial . Hypertension vol. 70 , ( 6 ) 1099 - 1105 .
Ott C, Lobo MD, Sobotka PA, Mahfoud F, Stanton A, Cockcroft J, Sulke N, Dolan E et al. ( 2016 ) . Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension . J Am Heart Assoc vol. 5 , ( 12 )
Floyd CN, Adeel MY, Wolff CB, Julu P, Shah M, Collier DJ, Saxena M, Brier T et al. ( 2016 ) . First-in-man treatment of severe blood pressure variability with baroreflex activation therapy . International Journal of Cardiology vol. 220 , Article C , 577 - 579 .
Lobo MD, Montarello J, Saxena M, Jain A, Walters D, Pincus M, Tsioufis C, Papademetriou V et al. ( 2016 ) . [OP.4C.04] SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS . J Hypertens vol. 34 Suppl 2 ,
Lobo MD, Adeel MY, Wolff CB, Julu PO, Shah M, Collier DM, Saxena M, Floyd C et al. ( 2016 ) . [OP.8D.02] FIRST IN MAN TREATMENT OF SEVERE BP VARIABILITY WITH BAROREFLEX ACTIVATION THERAPY . J Hypertens vol. 34 Suppl 2 , e105 - e105 .
Lobo M, Saxena M, Sobotka PA, Ott C, Dolan E, Foran J, Furniss SS, Cockcroft J et al. ( 2016 ) . [OP.LB.02.04] CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS FOR UNCONTROLLED HYPERTENSION: 12 MONTH FOLLOW UP RESULTS OF THE ROX CONTROL HTN RANDOMISED CONTROLLED TRIAL . J Hypertens vol. 34 Suppl 2 , e78 - e79 .
Lobo MD, Montarello J, Saxena M, Jain AK, Walters D, Pincus M, Worthley SG ( 2016 ) . [PP.26.11] RENAL DENERVATION USING THE ENLIGHTN RENAL DENERVATION SYSTEM IN ALTERNATIVE HYPERTENSIVE POPULATIONS . Journal of Hypertension . vol. 34 ,
Wolff C, Julu PO, Collier DJ, Saxena M, Kapil V, Shah M, Eftychiou S, Mills E et al. ( 2016 ) . [PP.38.09] EFFECTS OF MILD DYNAMIC EXERCISE ON CIRCULATORY AND AUTONOMIC FUNCTION IN HEALTHY VOLUNTEERS . Journal of Hypertension . vol. 34 , e351 - e352 .
Saxena M, Sobotka PA, Hamshere SM, Jain A, Mathur A, Knight C, Collier DJ, Lobo MD ( 2016 ) . Antihypertensive effects of a central arteriovenous anastomosis are mediated through profound reduction in systemic vascular resistance . Circulation: Cardiovascular Interventions vol. 9 , ( 8 )
Ng FL, Saxena M, Mahfoud F, Pathak A, Lobo MD ( 2016 ) . Device-based Therapy for Hypertension . Curr Hypertens Rep vol. 18 , ( 8 ) 61 - 61 .
Burchell AE, Chan K, Ratcliffe LEK, Hart EC, Saxena M, Collier DJ, Jain AK, Mathur A et al. ( 2016 ) . Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers . Journal of Clinical Hypertension vol. 18 , ( 6 ) 585 - 592 .
De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MMA, Böhm M, Daemen J et al. ( 2016 ) . Renal denervation in hypertensive patients not on blood pressure lowering drugs . Clinical Research in Cardiology vol. 105 , ( 9 ) 755 - 762 .
Saxena M, Antoniou S, Hamedi N, Robinson P, Singh H, Mukhtar O, Kapil V, Lobo MD ( 2016 ) . Multiple drug-intolerant hypertension: A case series utilising a novel-treatment algorithm . British Journal of General Practice vol. 66 , ( 645 ) e285 - e287 .
Antoniou S, Saxena M, Hamedi N, de Cates C, Moghul S, Lidder S, Kapil V, Lobo MD ( 2016 ) . Management of Hypertensive Patients With Multiple Drug Intolerances: A Single-Center Experience of a Novel Treatment Algorithm . Journal of Clinical Hypertension vol. 18 , ( 2 ) 129 - 138 .
Wolff CB, Collier DJ, Shah M, Saxena M, Brier TJ, Kapil V, Green D, Lobo M ( 2016 ) . A discussion on the regulation of blood flow and pressure . Advances in Experimental Medicine and Biology vol. 876 , 129 - 135 .
Saxena M, Collier D, Jain A, Mathur A, Knight C, Sobotka P, Lobo M ( 2015 ) . A central iliac arteriovenous anastomosis results in durable and substantial blood pressure reduction in a woman with uncontrolled hypertension and multiple antihypertensive drug intolerances . JOURNAL OF HUMAN HYPERTENSION vol. 29 , ( 10 ) 631 - 632 .
Lobo MD, Montarello J, Saxena M, Jain AK, Walters D, Pincus M, Worthley SG ( 2015 ) . Safety and performance of the EnligHTN renal denervation system in patients with severe uncontrolled hypertension: 12 month results from the EnligHTN II Study . JOURNAL OF HUMAN HYPERTENSION vol. 29 , ( 10 ) 631 - 631 .
Lobo M, Montarello J, Saxena M, Jain A, Walters D, Pincus MW, Worthley SG ( 2015 ) . TCT-771 Safety and Performance of the EnligHTN Renal Denervation System in Patients with Uncontrolled Hypertension and Chronic Kidney Disease: 12 Month Results from the EnligHTN II Study . Journal of the American College of Cardiology . vol. 66 , b313 - b314 .
Worthley SG, Montarello J, Saxena M, Jain A, Walters D, Pincus MW, Tsioufis KP, Papademetriou V et al. ( 2015 ) . TCT-774 Safety and Performance of the EnligHTN™ Renal Denervation System in Patients with Drug-resistant Hypertension: Pooled analyses from the EnligHTN I, II and III trials . Journal of the American College of Cardiology . vol. 66 ,
Lobo M, Montarello J, Saxena M, Jain A, Walters D, Pincus MW, Worthley SG ( 2015 ) . TCT-85 Safety and Performance of the EnligHTN Renal Denervation System in Patients with Severe Uncontrolled Hypertension: 12 Month Results from the EnligHTN II Study . Journal of the American College of Cardiology . vol. 66 , b39 - b40 .
Kapil V, Sobotka PA, Saxena M, Mathur A, Knight C, Dolan E, Stanton A, Lobo MD ( 2015 ) . Central Iliac Arteriovenous Anastomosis for Hypertension: Targeting Mechanical Aspects of the Circulation . Current Hypertension Reports vol. 17 , ( 9 )
Burchell AE, Chan K, Hart EC, Saxena M, Jain AK, Collier DJ, Paton JFR, Nightingale AK et al. ( 2015 ) . Challenges facing renal denervation: insight from real world experience at two UK centres . EUROPEAN HEART JOURNAL . vol. 36 , 505 - 506 .
Lobo M, Saxena M, Jain AJ, Walters D, Pincus M, Montarello J, Worthley SG ( 2015 ) . 4A.09 . Journal of Hypertension . vol. 33 ,
Saxena M, Collier D, Jain A, Knight C, Mathur A, Sobotka P, Lobo M ( 2015 ) . 8C.09 . Journal of Hypertension . vol. 33 ,
Antoniou S, Saxena M, Hamedi N, De Cates C, Moghul S, Lidder S, Lobo M, Kapil V ( 2015 ) . PP.21.35 . Journal of Hypertension . vol. 33 ,
Worthley S, Montarello J, Saxena M, Jain A, Walters D, Pincus M, Tsioufis C, Papademetriou V et al. ( 2015 ) . PP.26.05 . Journal of Hypertension vol. 33 , ( &NA; )
Lobo M, Saxena M, Jain A, Walters D, Pincus M, Montarello J, Worthley S ( 2015 ) . PP.26.22 . Journal of Hypertension vol. 33 , ( &NA; )
Lobo M, Saxena M, Jain A, Walters D, Pincus M, Montarello J, Worthley S ( 2015 ) . PP.26.23 . Journal of Hypertension vol. 33 , ( &NA; ) e363 - e364 .
Worthley S, Montarello J, Saxena M, Jain A, Walters D, Pincus M, Tsioufis C, Papademetriou V et al. ( 2015 ) . SAFETY AND PERFORMANCE OF THE ENLIGHTN (TM) RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN I, II AND III TRIALS . JOURNAL OF HYPERTENSION . vol. 33 , E359 - E359 .
Lobo M, Saxena M, Jain A, Walters D, Pincus M, Montarello J, Worthley S ( 2015 ) . SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH MODERATE UNCONTROLLED HYPERTENSION: 12 MONTH RESULTS FROM THE ENLIGHTN II STUDY . JOURNAL OF HYPERTENSION . vol. 33 , E363 - E364 .
Lobo M, Saxena M, Jain A, Walters D, Pincus M, Montarello J, Worthley S ( 2015 ) . SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH UNCONTROLLED HYPERTENSION AND CHRONIC KIDNEY DISEASE: 12 MONTH RESULTS FROM THE ENLIGHTN II STUDY . JOURNAL OF HYPERTENSION . vol. 33 , E363 - E363 .
Antoniou S, Hamedi N, Lidder S, Saxena M, Brier T, Robinson P, Kapil V, Lobo M ( 2015 ) . CP-081 Management of uncontrolled blood pressure in patients with multiple drug intolerance referred to a specialist hypertension clinic . European Journal of Hospital Pharmacy vol. 22 , ( Suppl 1 )
Saxena M, Antoniou S, Hamedi N, Chowdhury R, Lidder S, Brier T, Robinson P, Kapil V et al. ( 2014 ) . Anti-hypertensive medicine intolerance - an overlooked and important cause of failed compliance . JOURNAL OF HUMAN HYPERTENSION vol. 28 , ( 10 ) 633 - 633 .
Saxena M, Jain A, Mathur A, Knight C, Caulfield M, Collier D, Lobo M ( 2014 ) . Early reduction in blood pressure and heart rate variability following multielectrode radio-frequency renal denervation in medicines intolerant patients . JOURNAL OF HUMAN HYPERTENSION . vol. 28 , 647 - 647 .
Burchell A, Chan K, Ratcliffe L, Hart E, Saxena M, Collier D, Jain A, Mathur A et al. ( 2014 ) . Highly variable response to renal denervation for resistant hypertension - real world experience from 2 UK centres . JOURNAL OF HUMAN HYPERTENSION . vol. 28 , 645 - 646 .
Antoniou S, Hamedi N, Choudhury R, Lidder S, Saxena M, Brier T, Robinson P, Kapil V et al. ( 2014 ) . Management of uncontrolled blood pressure in patients referred to a specialist hypertension clinic with multiple medicines intolerance . JOURNAL OF HUMAN HYPERTENSION vol. 28 , ( 10 ) 645 - 645 .
Saxena M, Collier D, Caulfield M, Lobo M ( 2012 ) . Patients with resistant hypertension warrant a trial of salt restriction before and after renal denervation (RD) . JOURNAL OF HUMAN HYPERTENSION vol. 26 , ( 10 ) 619 - 619 .
Chan K, Ng FL, Saxena M, Collier D, Matson M, Jain A, Caulfield M, Lobo M ( 2012 ) . Renal denervation in resistant hypertension-a prospective case series . JOURNAL OF HUMAN HYPERTENSION vol. 26 , ( 10 ) 631 - 631 .
Collier DJ, Robson J, Scott R, Will CM, Eldridge SE, Griffiths CJ, Badrick E, Saxena M et al. ( 2010 ) . HiLo: a health services intervention study: methods and interim results on the first 2000 patients at 1 year . J HUM HYPERTENS vol. 24 , ( 10 ) 708 - 709 .